Brief: Biotec's Woulgan application to be reconsidered by UK Drug Tariff
12/09/2017 13:02
Sept 12 (Reuters) - BIOTEC PHARMACON ASA BIOTEC.OL :
* BIOTEC BETAGLUCANS HAS RECEIVED POSITIVE FEEDBACK FROM UK
DRUG TARIFF APPEAL PANEL
* UK DRUG TARIFF APPEAL PANEL WILL RECONSIDER BIOTEC'S
APPLICATION FOR REIMBURSEMENT OF WOULGAN
Source text for Eikon: ID:nWkrY9nbm
Further company coverage: BIOTEC.OL
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))